Deletion of the last exon of SHANK3 gene produces the full Phelan-McDermid phenotype: a case report.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Gene

• Publication date

  2013-07-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.gene.2013.03.141PMID 23612248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SHANK3 as an autism spectrum disorder-associated gene.

  2013cited by this paper
• Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills

  2012cited by this paper
• High Proportion of 22q13 Deletions and SHANK3 Mutations in Chinese Patients with Intellectual Disability

  2012cited by this paper
• Development and Validation of Computational Fluid Dynamics Models for Prediction of Heat Transfer and Thermal Microenvironments of Corals

  2012cited by this paper
• A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan–McDermid syndrome and hypergonadotropic hypogonadism

  2011influential reference
• The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)

  2011cited by this paper
• Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism.

  2011cited by this paper
• Shank3 mutant mice display autistic-like behaviours and striatal dysfunction

  2011cited by this paper
• Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome

  2011influential reference
• Association between deletion size and important phenotypes expands the genomic region of interest in Phelan–McDermid syndrome (22q13 deletion syndrome)

  2011influential reference
• Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies.

  2011cited by this paper
• Deletion Syndrome : Clinical and Molecular Analysis Using Array CGH

  2010influential reference
• Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication

  2010cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review Deletion 22q13.3 syndrome

  2008cited by this paper
• Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood

  2008cited by this paper
• Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders

  2007cited by this paper
• Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation

  2005cited by this paper
• Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome

  2005cited by this paper
• Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons

  2005cited by this paper
• Acrosin and the acrosome in human spermatogenesis

  2004cited by this paper
• Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

  2003cited by this paper
• Regulation of dendritic spine morphology and synaptic function by Shank and Homer.

  2001cited by this paper
• Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin.

  1999influential reference
• Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia.

  1997cited by this paper
• Acrosin, the peculiar sperm-specific serine protease

  1991cited by this paper
• Copper and Cholera

  1883cited by this paper

• Early-onset catatonia associated with SHANK3 mutations: looking at the autism spectrum through the prism of psychomotor phenomena

  2023cites this paper
• Head Size in Phelan–McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13

  2023cites this paper
• Descriptive Analysis of Adaptive Behavior in Phelan–McDermid Syndrome and Autism Spectrum Disorder

  2022cites this paper
• DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome

  2021cites this paper
• A systematic review of brain MRI findings in monogenic disorders strongly associated with autism spectrum disorder.

  2021cites this paper
• Bringing everyone to the table – findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference

  2020cites this paper
• Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment

  2019cites this paper
• Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature

  2019cites this paper
• Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome

  2018cites this paper
• Clinical characterization of novel chromosome 22q13 microdeletions.

  2017cites this paper
• Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome).

  2017cites this paper
• Phelan‐McDermid syndrome data network: Integrating patient reported outcomes with clinical notes and curated genetic reports

  2017cites this paper
• Phelan–McDermid Syndrome: Clinical Aspects

  2016cites this paper
• Concomitant 11p15.4‐p15.5 duplication and terminal 22q13.33 deletion in a patient with features of Beckwith–Wiedemann syndrome

  2016cites this paper
• Modeling SHANK2 Related Neuropsychiatric Disorders in Mice

  2015cites this paper